NCT06974253 Morphological Characteristics of Anterior Maxillary Bone and Dynamic Navigation in Full-Arch Implant Placement
| NCT ID | NCT06974253 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Medicine and Pharmacy at Ho Chi Minh City |
| Condition | Atrophy of Edentulous Maxillary Alveolar Ridge |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-05-30 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-05-30 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to evaluate the effectiveness of dynamic navigation in full-arch dental implant placement in patients with complete maxillary edentulism. The main questions it aims to answer are: * the accuracy of nasopalatine implants, trans-sinus implants, and trans-nasal implants placement in the anterior maxillary bone with dynamic navigation * the clinical effectiveness of nasopalatine implants, trans-sinus implants, and trans-nasal implants in full-arch rehabilitation * the correlation between the anatomical features of the nasal cavity and the anterior sinus wall on CBCT images and their influence on nasopalatine implants, trans-sinus implants, and trans-nasal implants position
Eligibility Criteria
Inclusion Criteria: * Aged 18 years or older * Good overall health (Class 1 and 2 according to the American Society of Anesthesiologists classification system) * Clinical diagnosis of complete edentulism of the upper arch classified as Class IV to VI according to Cawood and Howell Exclusion Criteria: * Systemic or local conditions that may affect surgery, wound healing, or bone integration, such as cardiovascular diseases, diabetes, bone-related diseases, or medication affecting bone metabolism * Smoking more than 10 cigarettes per day * Presence of acute infections in the planned implant site * Limited mouth opening of less than 40mm
Contact & Investigator
Lam Tan Bui, MSc
PRINCIPAL INVESTIGATOR
Faculty of Dentistry, University of Medicine and Pharmacy at Ho Chi Minh City
Frequently Asked Questions
Who can join the NCT06974253 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Atrophy of Edentulous Maxillary Alveolar Ridge. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06974253 currently recruiting?
Yes, NCT06974253 is actively recruiting participants. Contact the research team at buitanlam@ump.edu.vn for enrollment information.
Where is the NCT06974253 trial being conducted?
This trial is being conducted at Ho Chi Minh City, Vietnam.
Who is sponsoring the NCT06974253 clinical trial?
NCT06974253 is sponsored by University of Medicine and Pharmacy at Ho Chi Minh City. The principal investigator is Lam Tan Bui, MSc at Faculty of Dentistry, University of Medicine and Pharmacy at Ho Chi Minh City. The trial plans to enroll 20 participants.